Preclinical Evidence

Navigation

Preclinical Evidence

2013
Indian J Exp Biol. 2013;51(5):363–74.

In a study by Central Drug Research Institute, Lucknow, India, different extracts of heart wood of P. marsupium were tested for antidiabetic efficacy in streptozotocin (STZ)-induced diabetic rats.

Treatment showed a marked improvement on oral glucose tolerance post sucrose load as well as reduction in elevated blood glucose levels in diabetic rats. Furthermore, 10-day treatment with the ethanolic extract (100 mg/kg) resulted in decreased blood glucose, improved OGTT and increased serum insulin levels in STZ-treated rats.

When high-fat diet fed-low dosed STZ-treated diabetic rats were treated with ethanolic extract of P. marsupium for 28 consecutive days, altered renal and hepatic function markers and serum insulin levels were found to be normalized.

A dose-dependent increased glucose uptake by skeletal muscle cells (C2C12) was witnessed in the presence of phenolic C-glycosides isolated from ethanolic extract of P. marsupium. Overall, it was concluded that phenolic-C-glycosides present in P. marsupium heart wood are the phytoconstituents responsible for the antihyperglycemic activity, thus validating the claim of antidiabetic activity of heart wood of P. marsupium.

<< back